Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Omni Shoreham Hotel

Dec 05, 2016 1:00 PM - Dec 06, 2016 5:00 PM

2500 Calvert Street NW, , Washington, DC 20008 , USA

Advancing the Science of Study Endpoints

Examine global strategies for selecting study endpoints and the impact of endpoints during the analysis of clinical evidence for various types of drug approval processes.

Closing Summary

Session Chair(s)

Chad  Gwaltney, PHD

Chad Gwaltney, PHD

President, Gwaltney Consulting, United States

Closing Summary

Speaker(s)

René  Allard, PHD

René Allard, PHD

Contractor, CTC, Germany

Panelist

J. Jason  Lundy, PHD

J. Jason Lundy, PHD

Principal , Outcometrix, United States

Panelist

David H. Schubert

David H. Schubert

, United States

Panelist

Ashley F. Slagle, PHD, MS

Ashley F. Slagle, PHD, MS

Principal, Scientific and Regulatory Consulting, Aspen Consulting, LLC, United States

Panelist

Keith  Wenzel

Keith Wenzel

Volunteer, DIA Study Endpoints Community, United States

Panelist

Elektra  Papadopoulos, MD, MPH

Elektra Papadopoulos, MD, MPH

Director, Patient Experience Data and Strategy, AbbVie, United States

Panelist

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.